Literature DB >> 5838729

A large environmental chamber for the study of hypercapnia and hypoxia.

W B Schwartz, L Silverman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5838729     DOI: 10.1152/jappl.1965.20.4.767

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


× No keyword cloud information.
  7 in total

1.  Regulation of acid-base equilibrium in chronic hypocapnia. Evidence that the response of the kidney is not geared to the defense of extracellular (H+).

Authors:  J J Cohen; N E Madias; C J Wolf; W B Schwartz
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

2.  The maladaptive renal response to secondary hypocapnia during chronic HCl acidosis in the dog.

Authors:  N E Madias; W B Schwartz; J J Cohen
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  The effects of chronic hypoxemia on electrolyte and acid-base equilibrium: an examination of normocapneic hypoxemia and of the influence of hypoxemia on the adaptation to chronic hypercapnia.

Authors:  D G Sapir; D Z Levine; W B Schwartz
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

4.  Renal acidification during chronic hypercapnia in the conscious dog.

Authors:  H J Adrogué; N E Madias
Journal:  Pflugers Arch       Date:  1986-05       Impact factor: 3.657

5.  Influence of steady-state alterations in acid-base equilibrium on the fate of administered bicarbonate in the dog.

Authors:  H J Adrogué; J Brensilver; J J Cohen; N E Madias
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

6.  The nature of the renal adaptation to chronic hypocapnia.

Authors:  F J Gennari; M B Goldstein; W B Schwartz
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

7.  The influence of graded degrees of chronic hypercapnia on the acute carbon dioxide titration curve.

Authors:  M B Goldstein; F J Gennari; W B Schwartz
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.